Table 1 Characteristics of the included studies
Author | Year | Study type | Operation | TXA route | TXA group | Control group | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Sample | Age | Intervention | Sample | Age | Intervention | |||||
Chen | 2020 | RCS | HTO | IV&Topical | 52 | 58.3 ± 10.4 | TXA | 48 | 56.6 ± 10.2 | None |
Kim | 2018 | RCS | HTO | IV | 75 | 55.0 ± 6.8 | TXA | 75 | 55.7 ± 5.5 | None |
Ni | 2020 | PCS | HTO | IV | 50 | 52.5 ± 2.8 | TXA | 50 | 52.9 ± 3.1 | Normal saline |
Palanisamy | 2018 | RCS | HTO | IV | 66 | 58 ± 5 | TXA | 86 | 57 ± 6 | None |
Suh | 2018 | RCS | HTO | Topical | 15 | 60 ± 5.6 | TXA | 15 | 56 ± 5.7 | None |